Literature DB >> 11249901

Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction.

K A Bybee1, R S Wright, B A Williams, J G Murphy, D R Holmes, S L Kopecky.   

Abstract

In a retrospective analysis, 66 patients identified as having received a statin drug within 24 hours of admission for acute myocardial infarction were matched 3:1 with a control group of 198 patients not treated with a statin agent. End points of in-hospital mortality and in-hospital reinfarction were significantly lower in the statin-treated group, pointing to a benefit from very early statin treatment in acute myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11249901     DOI： 10.1016/s0002-9149(00)01501-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Early use of statins in acute coronary syndromes.

Authors:  Joshua M Spin; Randall H Vagelos
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

2.  A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.

Authors:  Juan Antonio Gómez-Gerique; Roman Casciano; Lee Stern; Javier Rejas
Journal:  Eur J Health Econ       Date:  2004-10

3.  Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.

Authors:  S Perreault; L Blais; D Lamarre; A Dragomir; D Berbiche; L Lalonde; C Laurier; F St-Maurice; J Collin
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

4.  Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.

Authors:  Josef Veselka; Sárka Procházková; Radka Duchonová; Ingrid Homolová; David Tesar; Kevin A Bybee
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

Review 5.  Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction.

Authors:  Joseph B Muhlestein
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 6.  Lipid-lowering therapies in the management of acute coronary syndromes.

Authors:  Lori Mosca; Angelo Biviano
Journal:  Curr Cardiol Rep       Date:  2002-07       Impact factor: 2.931

Review 7.  Early use of statins in acute coronary syndromes.

Authors:  Joshua M Spin; Randall H Vagelos
Journal:  Curr Cardiol Rep       Date:  2002-07       Impact factor: 2.931

8.  Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS).

Authors:  C H Lee; P de Feyter; P W Serruys; F Saia; P A Lemos; D Goedhart; P R Soares; V A W M Umans; M Ciccone; M Cortellaro
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

Review 9.  Drug treatment of elderly patients with acute myocardial infarction: practical recommendations.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

10.  Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696].

Authors:  Petr Ostadal; David Alan; Petr Hajek; Jiri Vejvoda; Martin Mates; Peter Blasko; Josef Veselka; Milan Kvapil; Jiri Kettner; Martin Wiendl; Ondrej Aschermann; Josef Slaby; Eduard Nemecek; Frantisek Holm; Marek Rac; Milan Macek; Jana Cepova
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.